Why Testing for Both Infections Matters
Chlamydia and gonorrhea often travel together, and both can silently damage reproductive health if left untreated. Routine testing is the only reliable way to catch them early, especially since many people experience no obvious symptoms. The CDC recommends annual screening for sexually active people under 25 and for anyone with new or multiple partners. Getting tested protects your health and reduces the chance of passing the infections to others.
More from this site
Keep reading the latest coverage
How Chlamydia and Gonorrhea Tests Work
Most modern testing uses a urine sample or a swab from the affected area — the cervix, urethra, throat, or rectum — depending on the site of potential exposure. Nucleic acid amplification tests, or NAATs, are the gold standard because they detect the bacteria's genetic material with high sensitivity and specificity. Swab-based NAATs can be collected during a pelvic exam or a quick clinician visit, and urine-based NAATs offer a non-invasive alternative for cervical and urethral screening.
Testing Sites and Sample Types
- Urine sample: Non-invasive, commonly used for urethral and cervical screening.
- Vaginal or cervical swab: Often collected during a pelvic exam; self-swab options are available in some settings.
- Urethral swab: Used when symptoms suggest urethral infection.
- Throat or rectal swab: Recommended for people with oral or anal exposure, even without symptoms.
When You Should Get Tested
You should consider testing if you are sexually active and under 25, if you have a new sexual partner or multiple partners, or if a partner tells you they have an STI. Testing is also important during pregnancy, because untreated chlamydia and gonorrhea can cause complications such as preterm birth and transmission to the baby during delivery. Anyone with symptoms — unusual discharge, pain during urination, pelvic pain, or rectal discomfort — should seek testing promptly, regardless of sexual history.
Recommended Screening Intervals
| Risk Factor | Recommended Frequency |
|---|---|
| Sexually active women under 25 | Annual screening for chlamydia and gonorrhea |
| Women 25 and older with new or multiple partners | Annual or per-exposure testing |
| Men who have sex with men | At least annual; more often if multiple partners |
| Pregnant people | Screened at first prenatal visit |
| Anyone with a partner diagnosed with an STI | Test as soon as possible and again if symptoms develop |
What Your Results Mean
A positive result means the test detected chlamydia or gonorrhea DNA and an infection is present. A negative result is reassuring but does not guarantee you are STI-free if exposure was very recent, because there is a window period before the bacteria build up enough to be detected. If you test positive, a clinician will prescribe antibiotics. It is essential to complete the full course of medication and to avoid sex until treatment is finished and any partner has also been treated to prevent reinfection.
Where to Get Tested
Chlamydia and gonorrhea testing is available at primary care clinics, sexual health clinics, community health centers, and many pharmacies with walk-in lab services. Home-based STI test kits are also an option for those who prefer privacy, though they may not cover all exposure sites. Check whether the kit tests for both infections and for throat and rectal swabs if those are relevant to your history. Many public health programs and community clinics offer low-cost or free testing, and results are often available within a few days.
Prevention and Follow-Up
Using condoms consistently reduces the risk of both chlamydia and gonorrhea, but no method is 100 percent effective, which is why regular screening remains important. After treatment, ask your clinician about retesting three months later, since reinfection is common. Open communication with partners about STI status and testing history helps protect everyone involved and supports a culture of routine, stigma-free sexual health care.